雙成藥業(002693.SZ):監事周雲親屬短線交易及致歉
格隆匯5月13日丨雙成藥業(002693.SZ)公佈,公司於近日收到公司監事周雲出具的《關於本人親屬短線交易公司股票的情況及致歉聲明》,其配偶符儒遠為雙成藥業2021年股票期權與限制性股票激勵計劃股票期權的激勵對象,其於2022年5月6日至2022年5月11日期間買賣雙成藥業的股票。
根據周雲出具的《關於本人親屬短線交易公司股票的情況及致歉聲明》,周雲的配偶符儒遠通過其名下證券賬户買賣公司股票的情況如下:

根據《證券法》第四十四條,符儒遠買入公司股票後六個月內賣出股票的行為構成短線交易,上述交易所獲盈利 22.296萬元,計算公式為=(賣出均價-買入均價)*構成短線交易股份數量-相關的交易税費、佣金、融資利息。
截至目前,符儒遠尚持有公司股份25,000股。
根據《證券法》的規定,符儒遠已將本次短線交易收益全部上繳公司。
公司監事周雲和配偶符儒遠均深刻意識到該事項的嚴重性,積極配合核查並及時進行了糾正,就上述事項向公司董事會和廣大投資者致以誠摯的歉意,同時承諾將加強學習並自覺遵守《證券法》等相關規定,杜絕此類情況再次發生。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.